長期投資家のためのIR情報
バリュートレンド

【4502】武田薬品工業
製薬。中枢神経、消化器。本社は大阪市。

売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)
対前回 修正率 修正率 営業利益
(百万円)
対前回 修正率 修正率 経常利益
(百万円)
対前回 修正率 修正率 当期利益
(百万円)
対前回 修正率 修正率
2025.03 2024/10/31 Q2予 4,480,000 +3.0% +3.0% 265,000 +17.8% +17.8% 93,000 +69.1% +69.1% 68,000 +17.2% +17.2%
2025.03 2024/07/31 Q1予 4,350,000 0.0% 0.0% 225,000 0.0% 0.0% 55,000 0.0% 0.0% 58,000 0.0% 0.0%
2025.03 2024/05/09 当初予 4,350,000 - - - 225,000 - - - 55,000 - - - 58,000 - - -
2024.03 2024/05/09 4,263,762 +7.1% +11.0% 214,075 -4.9% -38.7% 52,791 -24.6% -71.5% 144,067 +54.9% +1.5%
2024.03 2024/02/01 Q3予 3,980,000 0.0% +3.6% 225,000 0.0% -35.5% 70,000 0.0% -62.2% 93,000 0.0% -34.5%
2024.03 2023/10/26 Q2予 3,980,000 +3.6% +3.6% 225,000 -35.5% -35.5% 70,000 -62.2% -62.2% 93,000 -34.5% -34.5%
2024.03 2023/07/27 Q1予 3,840,000 0.0% 0.0% 349,000 0.0% 0.0% 185,000 0.0% 0.0% 142,000 0.0% 0.0%
2024.03 2023/05/11 当初予 3,840,000 - - - 349,000 - - - 185,000 - - - 142,000 - - -
2023.03 2023/05/11 4,027,478 +2.5% +9.1% 490,505 -7.5% -5.7% 375,090 -12.0% -8.7% 317,017 +3.3% +8.6%
2023.03 2023/02/02 Q3予 3,930,000 0.0% +6.5% 530,000 0.0% +1.9% 426,000 0.0% +3.6% 307,000 0.0% +5.1%
2023.03 2022/10/27 Q2予 3,930,000 +6.5% +6.5% 530,000 +1.9% +1.9% 426,000 +3.6% +3.6% 307,000 +5.1% +5.1%
2023.03 2022/07/28 Q1予 3,690,000 0.0% 0.0% 520,000 0.0% 0.0% 411,000 0.0% 0.0% 292,000 0.0% 0.0%
2023.03 2022/05/11 当初予 3,690,000 - - - 520,000 - - - 411,000 - - - 292,000 - - -
2022.03 2022/05/11 3,569,006 +1.7% +5.9% 460,844 -10.5% -5.6% 302,571 -21.4% -14.0% 230,059 -5.1% -8.0%
2022.03 2022/02/03 Q3予 3,510,000 +4.2% +4.2% 515,000 +5.5% +5.5% 385,000 +9.4% +9.4% 242,500 +31.6% -3.0%
2022.03 2021/10/28 Q2予 3,370,000 0.0% 0.0% 488,000 0.0% 0.0% 352,000 0.0% 0.0% 184,300 -26.3% -26.3%
2022.03 2021/07/30 Q1予 3,370,000 0.0% 0.0% 488,000 0.0% 0.0% 352,000 0.0% 0.0% 250,000 0.0% 0.0%
2022.03 2021/05/11 当初予 3,370,000 - - - 488,000 - - - 352,000 - - - 250,000 - - -
2021.03 2021/05/11 3,197,812 -0.1% -1.6% 509,269 +17.3% +43.5% 366,235 +42.0% +83.1% 376,005 +108.3% +526.7%
2021.03 2021/02/04 Q3予 3,200,000 0.0% -1.5% 434,000 0.0% +22.3% 258,000 0.0% +29.0% 180,500 +45.6% +200.8%
2021.03 2020/10/29 Q2予 3,200,000 -1.5% -1.5% 434,000 +9.9% +22.3% 258,000 +12.2% +29.0% 124,000 +34.8% +106.7%
2021.03 2020/07/31 Q1予 3,250,000 0.0% 0.0% 395,000 +11.3% +11.3% 230,000 +15.0% +15.0% 92,000 +53.3% +53.3%
2021.03 2020/05/13 当初予 3,250,000 - - - 355,000 - - - 200,000 - - - 60,000 - - -
2020.03 2020/05/13 3,291,188 +0.2% -0.3% 100,408 +904.1% +152.0% -60,754 +56.6% +83.5% 44,241 +127.3% +111.6%
2020.03 2020/02/04 Q3予 3,286,000 +0.8% -0.4% 10,000 +109.1% +105.2% -140,000 +51.7% +62.1% -162,000 +40.7% +57.7%
2020.03 2019/10/31 Q2予 3,260,000 -1.2% -1.2% -110,000 +33.7% +43.0% -290,000 +15.2% +21.4% -273,000 +25.8% +28.7%
2020.03 2019/07/31 Q1予 3,300,000 0.0% 0.0% -166,000 +14.0% +14.0% -342,000 +7.3% +7.3% -367,700 +4.0% +4.0%
2020.03 2019/05/14 当初予 3,300,000 - - - -193,000 - - - -369,000 - - - -383,000 - - -
2019.03 2019/05/14 2,097,224 +0.0% +20.7% 204,969 -0.0% +2.0% 94,896 -0.1% -48.1% 109,126 -42.4% -21.5%
2019.03 2019/04/25 修正予 2,097,000 +19.8% +20.7% 205,000 -23.8% +2.0% 95,000 -61.3% -48.1% - - - -
2019.03 2019/02/01 Q3予 1,750,000 0.0% +0.7% 268,900 0.0% +33.8% 245,200 0.0% +34.0% 189,500 0.0% +36.3%
2019.03 2018/10/31 Q2予 1,750,000 +0.7% +0.7% 268,900 +33.8% +33.8% 245,200 +34.0% +34.0% 189,500 +36.3% +36.3%
2019.03 2018/07/31 Q1予 1,737,000 0.0% 0.0% 201,000 0.0% 0.0% 183,000 0.0% 0.0% 139,000 0.0% 0.0%
2019.03 2018/05/14 当初予 1,737,000 - - - 201,000 - - - 183,000 - - - 139,000 - - -
2018.03 2018/05/14 1,770,531 +1.5% +5.4% 241,789 +10.6% +34.3% 217,205 +12.5% +14.3% 186,886 +18.8% +35.4%
2018.03 2018/02/01 Q3予 1,745,000 +1.5% +3.9% 218,700 +9.3% +21.5% 193,000 -8.1% +1.6% 157,300 +3.5% +14.0%
2018.03 2017/11/01 Q2予 1,720,000 +2.4% +2.4% 200,000 +11.1% +11.1% 210,000 +10.5% +10.5% 152,000 +10.1% +10.1%
2018.03 2017/07/28 Q1予 1,680,000 0.0% 0.0% 180,000 0.0% 0.0% 190,000 0.0% 0.0% 138,000 0.0% 0.0%
2018.03 2017/05/10 当初予 1,680,000 - - - 180,000 - - - 190,000 - - - 138,000 - - -
2017.03 2017/05/10 1,732,051 +1.9% +0.7% 155,867 +15.5% +15.5% 143,346 +8.2% +8.2% 114,940 +23.6% +30.6%
2017.03 2017/02/01 Q3予 1,700,000 +1.8% -1.2% 135,000 0.0% 0.0% 132,500 0.0% 0.0% 93,000 +2.2% +5.7%
2017.03 2016/10/28 Q2予 1,670,000 -2.9% -2.9% 135,000 0.0% 0.0% 132,500 0.0% 0.0% 91,000 +3.4% +3.4%
2017.03 2016/07/29 Q1予 1,720,000 0.0% 0.0% 135,000 0.0% 0.0% 132,500 0.0% 0.0% 88,000 0.0% 0.0%
2017.03 2016/05/10 当初予 1,720,000 - - - 135,000 - - - 132,500 - - - 88,000 - - -
2016.03 2016/05/10 1,807,378 -0.7% -0.7% 130,828 +9.0% +24.6% 120,539 +4.8% +4.8% 80,166 +17.9% +17.9%
2016.03 2016/02/03 Q3予 1,820,000 0.0% 0.0% 120,000 +14.3% +14.3% 115,000 0.0% 0.0% 68,000 0.0% 0.0%
2016.03 2015/10/30 Q2予 1,820,000 0.0% 0.0% 105,000 0.0% 0.0% 115,000 0.0% 0.0% 68,000 0.0% 0.0%
2016.03 2015/07/30 Q1予 1,820,000 0.0% 0.0% 105,000 0.0% 0.0% 115,000 0.0% 0.0% 68,000 0.0% 0.0%
2016.03 2015/05/15 当初予 1,820,000 - - - 105,000 - - - 115,000 - - - 68,000 - - -
2015.03 2015/05/15 1,777,824 +0.2% +3.1% -129,254 +0.6% -186.2% -145,437 -0.3% -203.9% -145,775 -0.5% -271.5%
2015.03 2015/04/29 修正予 1,775,000 +2.9% +2.9% -130,000 -176.5% -186.7% -145,000 -190.6% -203.6% -145,000 -323.1% -270.6%
2015.03 2015/02/05 Q3予 1,725,000 0.0% 0.0% 170,000 +13.3% +13.3% 160,000 +14.3% +14.3% 65,000 -23.5% -23.5%
2015.03 2014/10/30 Q2予 1,725,000 0.0% 0.0% 150,000 0.0% 0.0% 140,000 0.0% 0.0% 85,000 0.0% 0.0%
2015.03 2014/08/01 Q1予 1,725,000 0.0% 0.0% 150,000 0.0% 0.0% 140,000 0.0% 0.0% 85,000 0.0% 0.0%
2015.03 2014/05/08 当初予 1,725,000 - - - 150,000 - - - 140,000 - - - 85,000 - - -
2014.03 2014/05/08 1,691,685 - - - 139,274 - - - 158,851 - - - 106,658 - - -
ページトップへ戻る